drugset / Trial / NCT03105830

Pain Management at Latent Period of Labour

NCT03105830

Unknown 150 enrolled Western Galilee Hospital-Nahariya
NaSingle-groupOpen-labelTreatment

Summary

Examine the effectiveness of an analgesic in PERFALGAN maternity latent phase of labor. Examine the safety in PERFALGAN in the mother and the newborn in terms of the level of drug in blood

Timeline

Start
2017-05
Primary completion
2018-04-20
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1 g Intravenous

Indications

No indication recorded.